UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The Absence of a Clinically Significant Effect of Food on the Single Dose Pharmacokinetics of Vorapaxar, a PAR-1 Antagonist, in Healthy Adult Subjects

Clinical pharmacology in drug development, 2013-10, Vol.2 (4), p.310-315

2013

Volltextzugriff (PDF)

Assessment of potential pharmacokinetic interactions of ezetimibe/simvastatin and extended-release niacin tablets in healthy subjects

European journal of clinical pharmacology, 2011-05, Vol.67 (5), p.483-492

2011

Volltextzugriff (PDF)

Disposition of 14C-eptifibatide after intravenous administration to healthy men

Clinical therapeutics, 1998-03, Vol.20 (2), p.307-323

1998

Volltextzugriff (PDF)

Drug interactions involving renal transport mechanisms: an overview

DICP (Cincinnati, Ohio), 1989-02, Vol.23 (2), p.116-122

1989

Volltextzugriff (PDF)

The effect of fluvastatin on the pharmacokinetics and pharmacodynamics of ezetimibe

Current medical research and opinion, 2005-08, Vol.21 (8), p.1171-1179

2005

Volltextzugriff (PDF)

Effect of Food, Antacid, and Age on the Pharmacokinetics of the Oral Thrombin Receptor Antagonist Vorapaxar (SCH 530348) in Healthy Volunteers

Clinical pharmacology in drug development, 2013-07, Vol.2 (3), p.223-230

2013

Volltextzugriff (PDF)

Effect of the thrombin receptor antagonist (PAR-1) vorapaxar on QT/QTc interval in healthy volunteers: A randomized, placebo- and positive-controlled, parallel group trial

Clinical pharmacology in drug development, 2014-01, Vol.3 (1), p.18-24

2014

Volltextzugriff (PDF)

Effects of ezetimibe on the pharmacodynamics and pharmacokinetics of lovastatin

Current medical research and opinion, 2004-06, Vol.20 (6), p.955-965

2004

Volltextzugriff (PDF)

Effects of SCH 34826, an orally active inhibitor of atrial natriuretic peptide degradation, in healthy volunteers

Clinical pharmacology and therapeutics, 1991-08, Vol.50 (1), p.181-191

1991

Volltextzugriff (PDF)

Evaluation of potential for pharmacokinetic interaction between mometasone furoate and formoterol fumarate after oral inhalation from a fixed-dose combination metered-dose inhaler device

Clinical pharmacology in drug development, 2014-05, Vol.3 (3), p.222-228

2014

Volltextzugriff (PDF)

An evaluation of the systemic bioavailability of mometasone furoate (MF) after oral inhalation from a MF/formoterol fumarate metered-dose inhaler versus an MF dry-powder inhaler in healthy subjects

Clinical pharmacology in drug development, 2014-05, Vol.3 (3), p.229-234

2014

Volltextzugriff (PDF)

Ezetimibe : A review of its metabolism, pharmacokinetics and drug interactions

Clinical pharmacokinetics, 2005-01, Vol.44 (5), p.467-494

2005

Volltextzugriff (PDF)

The Influence of Multiple-Dose Vorapaxar, an Oral PAR-1 Receptor Antagonist, on the Single-Dose Pharmacokinetics and Pharmacodynamics of Digoxin

Clinical pharmacology in drug development, 2013-01, Vol.2 (1), p.90-98

2013

Volltextzugriff (PDF)

Mometasone furoate nasal spray : A review of safety and systemic effects

Drug safety, 2007-01, Vol.30 (4), p.317-326

2007

Volltextzugriff (PDF)

Neutral endopeptidase inhibition: augmented atrial and brain natriuretic peptide, haemodynamic and natriuretic responses in ovine heart failure

Clinical science (1979), 1996-09, Vol.91 (3), p.283-291

1996

Volltextzugriff (PDF)

No differences in the pharmacodynamics and pharmacokinetics of the thrombin receptor antagonist vorapaxar between healthy Japanese and Caucasian subjects

European journal of clinical pharmacology, 2012-03, Vol.68 (3), p.291-300

2012

Volltextzugriff (PDF)

No Pharmacokinetic Drug–Drug Interaction Between Prasugrel and Vorapaxar Following Multiple‐Dose Administration in Healthy Volunteers

Clinical pharmacology in drug development, 2018-02, Vol.7 (2), p.143-150

2018

Volltextzugriff (PDF)

Pharmacodynamic and pharmaco-kinetic interaction between fenofibrate and ezetimibe

Current medical research and opinion, 2004-08, Vol.20 (8), p.1197-1207

2004

Volltextzugriff (PDF)

Pharmacodynamic and pharmacokinetic interaction between fenofibrate and ezetimibe

Current medical research and opinion, 2004-08, Vol.20 (8), p.1197

2004

Volltextzugriff (PDF)

Pharmacodynamic interaction between ezetimibe and rosuvastatin

Current medical research and opinion, 2004-08, Vol.20 (8), p.1185-1195

2004

Volltextzugriff (PDF)

Pharmacodynamics and pharmacokinetics of the novel PAR-1 antagonist vorapaxar (formerly SCH 530348) in healthy subjects

European journal of clinical pharmacology, 2012-03, Vol.68 (3), p.249-258

2012

Volltextzugriff (PDF)

Pharmacokinetic interaction between ezetimibe and lovastatin in healthy volunteers

Current medical research and opinion, 2004-09, Vol.20 (9), p.1493-1500

2004

Volltextzugriff (PDF)

Pharmacokinetics and pharmacodynamics of the novel PAR-1 antagonist vorapaxar in patients with end-stage renal disease

European journal of clinical pharmacology, 2012-07, Vol.68 (7), p.1049-1056

2012

Volltextzugriff (PDF)

Pharmacokinetics of isosorbide-5-mononitrate after oral administration of an extended-release mononitrate formulation versus a standard dinitrate formulation

Clinical therapeutics, 1995-03, Vol.17 (2), p.241-251

1995

Volltextzugriff (PDF)

Pharmacokinetics of loratadine and pseudoephedrine following single and multiple doses of once- versus twice-daily combination tablet formulations in healthy adult males

Clinical therapeutics, 1997-09, Vol.19 (5), p.1002-1012

1997

Volltextzugriff (PDF)

1 – 25 von 32

Suche als RSS-Feed

Aktive Filter

KollektionEZB Free E-Journals

Zeitschrift / SerieJournal Of Clinical Pharmacology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(31)
Mit Volltextzugriff
(26)

Publikationsform

Artikel
(32)

Sprache

Englisch
(32)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(28)
Science & Technology
(28)
Humans
(24)
Pharmacology & Pharmacy
(23)
Male
(22)
Adult
(20)
Pharmacokinetics
(19)
Biological And Medical Sciences
(17)
Medical Sciences
(16)
Pharmacology. Drug Treatments
(16)
Female
(15)
Middle Aged
(12)
Vorapaxar
(12)
Drug Interactions
(11)
Ezetimibe
(9)
Pharmacodynamics
(9)
Adolescent
(8)
Area Under Curve
(8)
Azetidines - Pharmacokinetics
(8)
Anticholesteremic Agents - Pharmacokinetics
(7)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The Absence of a Clinically Significant Effect of Food on the Single Dose Pharmacokinetics of Vorapaxar, a PAR-1 Antagonist, in Healthy Adult Subjects

Assessment of potential pharmacokinetic interactions of ezetimibe/simvastatin and extended-release niacin tablets in healthy subjects

Disposition of 14C-eptifibatide after intravenous administration to healthy men

Drug interactions involving renal transport mechanisms: an overview

The effect of fluvastatin on the pharmacokinetics and pharmacodynamics of ezetimibe

Effect of Food, Antacid, and Age on the Pharmacokinetics of the Oral Thrombin Receptor Antagonist Vorapaxar (SCH 530348) in Healthy Volunteers

Effect of the thrombin receptor antagonist (PAR-1) vorapaxar on QT/QTc interval in healthy volunteers: A randomized, placebo- and positive-controlled, parallel group trial

Effects of ezetimibe on the pharmacodynamics and pharmacokinetics of lovastatin

Effects of SCH 34826, an orally active inhibitor of atrial natriuretic peptide degradation, in healthy volunteers

Evaluation of potential for pharmacokinetic interaction between mometasone furoate and formoterol fumarate after oral inhalation from a fixed-dose combination metered-dose inhaler device

An evaluation of the systemic bioavailability of mometasone furoate (MF) after oral inhalation from a MF/formoterol fumarate metered-dose inhaler versus an MF dry-powder inhaler in healthy subjects

Ezetimibe : A review of its metabolism, pharmacokinetics and drug interactions

The Influence of Multiple-Dose Vorapaxar, an Oral PAR-1 Receptor Antagonist, on the Single-Dose Pharmacokinetics and Pharmacodynamics of Digoxin

Mometasone furoate nasal spray : A review of safety and systemic effects

Neutral endopeptidase inhibition: augmented atrial and brain natriuretic peptide, haemodynamic and natriuretic responses in ovine heart failure

No differences in the pharmacodynamics and pharmacokinetics of the thrombin receptor antagonist vorapaxar between healthy Japanese and Caucasian subjects

No Pharmacokinetic Drug–Drug Interaction Between Prasugrel and Vorapaxar Following Multiple‐Dose Administration in Healthy Volunteers

Pharmacodynamic and pharmaco-kinetic interaction between fenofibrate and ezetimibe

Pharmacodynamic and pharmacokinetic interaction between fenofibrate and ezetimibe

Pharmacodynamic interaction between ezetimibe and rosuvastatin

Pharmacodynamics and pharmacokinetics of the novel PAR-1 antagonist vorapaxar (formerly SCH 530348) in healthy subjects

Pharmacokinetic interaction between ezetimibe and lovastatin in healthy volunteers

Pharmacokinetics and pharmacodynamics of the novel PAR-1 antagonist vorapaxar in patients with end-stage renal disease

Pharmacokinetics of isosorbide-5-mononitrate after oral administration of an extended-release mononitrate formulation versus a standard dinitrate formulation

Pharmacokinetics of loratadine and pseudoephedrine following single and multiple doses of once- versus twice-daily combination tablet formulations in healthy adult males

Aktive Filter

Suchergebnisse filtern